Search

Search Constraints

You searched for: Author/Creator Rösner, Thies

Search Results

1. An IgG3 switch variant of rituximab mediates enhanced complement‐dependent cytotoxicity against tumour cells with low CD20 expression levels. (7th January 2013)

2. Effector mechanisms of IgA antibodies against CD20 include recruitment of myeloid cells for antibody‐dependent cell‐mediated cytotoxicity and complement‐dependent cytotoxicity. (27th April 2017)

3. Enhancement of epidermal growth factor receptor antibody tumor immunotherapy by glutaminyl cyclase inhibition to interfere with CD47/signal regulatory protein alpha interactions. Issue 8 (18th June 2021)

4. Novel chimerized IgA CD20 antibodies: Improving neutrophil activation against CD20-positive malignancies. Issue 1 (1st January 2020)